Azilsartan medoxomil
- Generic Name
- Azilsartan medoxomil
- Brand Names
- Edarbyclor, Edarbi
- Drug Type
- Small Molecule
- Chemical Formula
- C30H24N4O8
- CAS Number
- 863031-21-4
- Unique Ingredient Identifier
- LL0G25K7I2
- Background
Azilsartan medoxomil is a prodrug that is broken down to azilsartan, which belongs in the angiotensin-receptor blocking (ARB) drug class. It is a selective AT1 subtype angiotensin II receptor antagonist. Azilsartan medoxomil is a relatively recently-developed antihypertensive drug that was first approved by the FDA in February 2011. Many guidelines recommend...
- Indication
Azilsartan medoxomil is indicated for the treatment of hypertension to lower blood pressure in patients over 18 years of age. It may be used either alone or in combination with other antihypertensive agents. Some antihypertensive drugs have lesser effects on blood pressure in black patients.
...
- Associated Conditions
- Albuminuria, Hypertension, Atrial Fibrillation
- Associated Therapies
- -
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.